Evidence-based Complementary and Alternative Medicine · 2005 · 245 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryAntiviral AgentsAntiviral PharmacologyBioactive Food ComponentsEnzyme InhibitionMedicinal PlantsNatural Product Drug DiscoveryAntiviral Natural ProductsAntiviral Structure-activity RelationshipsNatural Product Library ScreeningSevere Acute Respiratory SyndromeTannin-based Natural ProductsTea PolyphenolsViral Replication Control
SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CL(Pro)) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural product library consisting of 720 compounds for inhibitory activity against 3CL(Pro). Two compounds in the library were found to be inhibitive: tannic acid (IC(50) = 3 microM) and 3-isotheaflavin-3-gallate (TF2B) (IC(50) = 7 microM). These two compounds belong to a group of natural polyphenols found in tea. We further investigated the 3CL(Pro)-inhibitory activity of extracts from several different types of teas, including green tea, oolong tea, Puer tea and black tea. Our results indicated that extracts from Puer and black tea were more potent than that from green or oolong teas in their inhibitory activities against 3CL(Pro). Several other known compositions in teas were also evaluated for their activities in inhibiting 3CL(Pro). We found that caffeine, (-)-epigallocatechin gallte (EGCg), epicatechin (EC), theophylline (TP), catechin (C), epicatechin gallate (ECg) and epigallocatechin (EGC) did not inhibit 3CL(Pro) activity. Only theaflavin-3,3'-digallate (TF3) was found to be a 3CL(Pro) inhibitor. This study has resulted in the identification of new compounds that are effective 3CL(Pro) inhibitors.
18
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Dean D. Erdman, Goldsmith Cs, Zaki et al. · New England Journal of Medicine · 2003 · 4.5K citations
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Paul A. Rota, M. Steven Oberste, Stephan S. Monroe et al. · Science · 2003 · 2.6K citations · Full text
The Genome Sequence of the SARS-Associated Coronavirus
Marco A. Marra, Steven J.M. Jones, Caroline R. Astell et al. · Science · 2003 · 2.1K citations
Coronavirus Main Proteinase (3CL <sup>pro</sup> ) Structure: Basis for Design of Anti-SARS Drugs
K. Anand, John Ziebuhr, Parvesh Wadhwani et al. · Science · 2003 · 1.8K citations